Prometheus Biosciences, Inc. Debt to Equity Ratio 2021-2023 | RXDX
Current and historical debt to equity ratio values for Prometheus Biosciences, Inc. (RXDX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Prometheus Biosciences, Inc. debt/equity for the three months ending March 31, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-03-31 | $0.06B | $0.70B | 0.09 |
| 2022-12-31 | $0.07B | $0.68B | 0.10 |
| 2022-09-30 | $0.07B | $0.23B | 0.28 |
| 2022-06-30 | $0.05B | $0.19B | 0.24 |
| 2022-03-31 | $0.05B | $0.21B | 0.23 |
| 2021-12-31 | $0.03B | $0.24B | 0.14 |
| 2021-09-30 | $0.03B | $0.26B | 0.10 |
| 2021-06-30 | $0.03B | $0.28B | 0.11 |
| 2021-03-31 | $0.02B | $0.30B | 0.07 |
| 2020-12-31 | $0.03B | $0.03B | 1.09 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
